Der Urologe. Ausg. A最新文献_第7页

Aktuelles aus der DGU-Pressestelle. 德格新闻社的新消息

Der Urologe. Ausg. A Pub Date : 2022-02-01 DOI: 10.1007/s00120-022-01769-9

引用次数: 0

Mitteilungen der DGU. Mitteilungen der DGU.

Der Urologe. Ausg. A Pub Date : 2022-02-01 DOI: 10.1007/s00120-022-01771-1

引用次数: 0

[Pelvic exenteration in patients with locally advanced, symptomatic castration-resistant prostate cancer]. [局部晚期，有症状的去势抵抗性前列腺癌患者盆腔切除术]。

Der Urologe. Ausg. A Pub Date : 2022-02-01 Epub Date: 2021-08-23 DOI: 10.1007/s00120-021-01619-0

Saskia Kanzelmeyer, Mark Bludau, David Johannes Karl Paul Pfister, Axel Heidenreich

{"title":"[Pelvic exenteration in patients with locally advanced, symptomatic castration-resistant prostate cancer].","authors":"Saskia Kanzelmeyer, Mark Bludau, David Johannes Karl Paul Pfister, Axel Heidenreich","doi":"10.1007/s00120-021-01619-0","DOIUrl":"https://doi.org/10.1007/s00120-021-01619-0","url":null,"abstract":"Goal: The retrospective evaluation of clinical outcomes after palliative pelvic exenteration (PPE) in patients with subvesical and supravesical complications due to symptomatic locally advanced castration-resistant prostate cancer (CRPC).Patients and methods: In all, 84 patients with locally advanced and symptomatic CRPC underwent radical cystoprostatectomy (n = 71, 83.3%) or anterior and posterior exenteration (n = 13, 16.7%). Local staging was done via pelvic MRI (magnetic resonance imaging), cystoscopy, and rectoscopy. Systemic staging was performed by computed tomography of the thorax, abdomen pelvis, and skeletal scintigraphy. Perioperative complications were evaluated using the Clavien-Dindo classification. The primary study objective was symptom-free survival defined as absence of lower or upper urinary tract symptoms and absence of endoluminal or percutaneous intervention.Results: After a median follow-up of 43.5 (3-139) months, symptom-free survival at 1 and 3 years was 95.2% and 86.7%, respectively. In all, 86.7% of patients remained symptom-free for their remaining lifetime with respect to local symptoms. Overall survival at 1 and 3 years was 92.9% and 54.7%, respectively. Clavien-Dindo grade 2, 3, and 4 complications occurred in 19 (22.6%), 7 (8.3%), and 3 (3.6%) patients, respectively.Conclusion: With adequate patient selection, PPE is possible with a low complication rate and results in significant symptom relief in the lower or upper genitourinary tract in about 90% of patients, of whom more than 80% remain symptom-free for the remainder of their lives. Prerequisites for favorable surgical outcomes are patient selection, an interdisciplinary approach, and appropriate surgical expertise.","PeriodicalId":11123,"journal":{"name":"Der Urologe. Ausg. A","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00120-021-01619-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39336290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[52/m-Sterile leucocyturia, night sweats and left-sided flank pain : Preparation for the medical specialist examination: part 10]. [52/m无菌白血球、盗汗、左侧腰痛:医学专科检查准备:第10部分]。

Der Urologe. Ausg. A Pub Date : 2022-02-01 Epub Date: 2021-10-04 DOI: 10.1007/s00120-021-01646-x

Korbinian Klotz, Michael Reiter

引用次数: 0

GeSRU. 格斯鲁。

Der Urologe. Ausg. A Pub Date : 2022-02-01 DOI: 10.1007/s00120-022-01773-z

引用次数: 0

AUO. 友达。

Der Urologe. Ausg. A Pub Date : 2022-02-01 DOI: 10.1007/s00120-021-01746-8

引用次数: 0

[55/m-Right-sided testicular pain : Preparation for the medical specialist examination: part 12]. [55/m-右侧睾丸疼痛:医学专家检查的准备:第12部分]。